Mirae Asset Global Etfs Holdings Ltd. Harrow Health, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Harrow Health, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 14,643 shares of HROW stock, worth $768,903. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,643Holding current value
$768,903% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HROW
# of Institutions
138Shares Held
20.3MCall Options Held
700KPut Options Held
564K-
Opaleye Management Inc. Boston, MA3.99MShares$210 Million21.35% of portfolio
-
Private Capital Management, LLC Naples, FL2.71MShares$143 Million7.1% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$113 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.84MShares$96.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA719KShares$37.7 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $1.42B
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...